68.30 USD
↘ 0.09 (0.13%)PRE MARKET (AS OF 07:01 AM EDT)
BridgeBio Pharma, Inc. Common Stock
BBIONASDAQ • USD
Market: OPEN
BridgeBio Pharma, Inc. Common Stock (BBIO) trades at $68.30 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (27.5%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$68.40
High?$68.40
Low?$68.30
Prev. Close?$68.39
Volume?398
Avg. Volume?2.1M
VWAP?$68.40
Rel. Volume?0.00x
Bid / Ask
Bid?$65.47 × 100
Ask?$71.22 × 100
Spread?$5.75
Midpoint?$68.35
Valuation & Ratios
Market Cap?13.4B
Shares Out?195.5M
Float?149.1M
Float %?76.2%
P/E Ratio?N/A
P/B Ratio?-5.32
EPS?-$3.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Themes
Employees
839
Market Cap
14.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-06-27
Address
3160 PORTER DR.
PALO ALTO, CA 94304
Phone: (650) 391-9740
PALO ALTO, CA 94304
Phone: (650) 391-9740
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?90
Short Sent.?53
Piotroski F-Score?3/9Weak
Altman Z-Score?-3.17Distress
Confidence?58%Low
Short InterestVery High
Short % of Float?14.65%High
Short Interest?21.8M
Days to Cover?11.2
Free Float149.1M
Avg Daily Volume2.0M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.23Adequate
Quick Ratio?1.17Adequate
Cash Ratio?0.76Adequate
Debt/Equity?-0.98Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-5.32CHEAP▾
S&P97
P/S?18.75HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-32.1CHEAP▾
S&P97
EV/Sales?21.27HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?27.5%STRONG▾
Peers50
S&P77
ROA?-56.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-435389000
Enterprise Value?$15.2B
Fundamentals ratios updated end of day